Immunization with live attenuated rubella virus vaccine (HPV-77). Clinical and serological results in children and adolescents in Israel.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001831:Body Temperature; D002648:Child; D006224:Cricetinae; D046508:Culture Techniques; D004372:Ducks; D004622:Embryo, Mammalian; D004625:Embryo, Nonmammalian; D004912:Erythrocytes; D005076:Exanthema / Q000209:etiology; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006801:Humans; D007557:Israel; D007668:Kidney; D008199:Lymphadenitis / Q000209:etiology; D008598:Menstruation; D008722:Methods; D009437:Neuralgia / Q000209:etiology; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus; D013997:Time Factors; D014611:Vaccination; D014765:Viral Vaccines; D014776:Virus Cultivation
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines